Description: SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, mixed vitamins, antibiotics, and others. The company also provides medicines for digestive system, medicines for liver disorder, medicines for circulation system, cold medicines, nutritional supplements, health tonics, and others, as well as vitamins and energy drinks, and functional foods. The company was founded in 1929 and is based in Hwaseong-si, South Korea.
Home Page: www.sspharm.co.kr
35 Jeyakgongdan 2-gil
Hwaseong-si,
445-746
South Korea
Phone:
82 3 1353 6681
Officers
| Name | Title |
|---|---|
| Mr. Won-Kyu Kim | Chairman and Chief Exec. Officer |
| Byung-Eul Choi | Managing Director |
Exchange: KO
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.7952 |
| Price-to-Sales TTM: | 4.5093 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |